BamSEC and AlphaSense Join Forces
Learn More

BlossomHill Therapeutics, Inc. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.15
from S-1/A 7 pages BlossomHill Therapeutics, Inc. Executive Employment Agreement for Geoffrey Oxnard, M.D
12/34/56
EX-10.14
from S-1/A 7 pages BlossomHill Therapeutics, Inc. Executive Employment Agreement for Vincent Liptak, J.D., PH.D., M.B.A
12/34/56
EX-10.13
from S-1/A 7 pages BlossomHill Therapeutics, Inc. Executive Employment Agreement for Jason Keyes, M.B.A
12/34/56
EX-10.12
from S-1/A 7 pages BlossomHill Therapeutics, Inc. Executive Employment Agreement for Yishan Peter LI, PH.D., M.B.A
12/34/56
EX-10.11
from S-1/A 7 pages BlossomHill Therapeutics, Inc. Executive Employment Agreement for Jingrong Jean Cui, PH.D
12/34/56
EX-10.7
from S-1/A 2 pages BlossomHill Therapeutics, Inc. Non-Employee Director Compensation Policy Adopted: June 25, 2026
12/34/56
EX-10.4
from S-1/A 16 pages BlossomHill Therapeutics, Inc. 2026 Employee Stock Purchase Plan Adopted by the Board of Directors: June 25, 2026 Approved by the Stockholders: July 30, 2026
12/34/56
EX-10.2
from S-1/A 30 pages BlossomHill Therapeutics, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: June 25, 2026 Approved by the Stockholders: July 30, 2026
12/34/56
EX-10.1
from S-1/A 8 pages Indemnification Agreement
12/34/56
EX-10.10
from S-1 89 pages Lease by and Between Bmr-10255 Science Center LP, a Delaware Limited Partnership and BlossomHill Therapeutics, Inc., a Delaware Corporation
12/34/56
EX-10.9
from S-1 9 pages BlossomHill Therapeutics, Inc. Consulting Agreement Effective Date: August 15, 2025
12/34/56
EX-10.8
from S-1 13 pages BlossomHill Therapeutics, Inc. Severance Plan and Summary Plan Description Approved by the Board of Directors: June 25, 2026
12/34/56
EX-10.6
from S-1 35 pages BlossomHill Therapeutics, Inc. 2020 Equity Incentive Plan Stock Option Grant Notice
12/34/56
EX-10.5
from S-1 22 pages Amendment No. 3 to the 2020 Equity Incentive Plan
12/34/56
EX-10.4
from S-1 16 pages BlossomHill Therapeutics, Inc. 2026 Employee Stock Purchase Plan Adopted by the Board of Directors: June 25, 2026 Approved by the Stockholders: [ ]
12/34/56
EX-10.3
from S-1 10 pages BlossomHill Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.2
from S-1 30 pages BlossomHill Therapeutics, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: June 25, 2026 Approved by the Stockholders: [ ]
12/34/56
EX-10.1
from S-1 8 pages Indemnification Agreement
12/34/56
EX-10.12
from DRS 89 pages Lease by and Between Bmr-10255 Science Center LP, a Delaware Limited Partnership and BlossomHill Therapeutics, Inc., a Delaware Corporation
12/34/56
EX-10.11
from DRS 9 pages BlossomHill Therapeutics, Inc. Consulting Agreement Effective Date: August 15, 2025
12/34/56